OPT Congress (Booth 12)
Oligonucleotides & mRNA Therapeutics
Join WuXi AppTec at this year's OPT Congress, the premier conference for scientists involved in discovering and developing oligonucleotides as therapeutics. This year's conference will also include three conference programs dedicated to mRNA therapeutics.
We are proud to be presenting 2 posters at OPT 2024:
- High Throughput 3’-Tag-Seq Method for Detecting Off-Targets of siRNA
- DEL-Generated Endocytosis Receptor-Binding Peptides for Oligonucleotide Delivery
From assessment of cell-based delivery and siRNA knockdown effects to in vivo safety and efficacy testing, our comprehensive services platform can accelerate your lead optimization efforts. Request a one-on-one dedicated meeting by completing the brief form on the right.